-
1
-
-
69249221317
-
Establishing evidence for change in ovarian cancer surgery - proposing clinical trials of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomatosis
-
Chua T.C., Liauw W., Robertson G., and Morris D.L. Establishing evidence for change in ovarian cancer surgery - proposing clinical trials of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomatosis. Gynecol. Oncol. (2009)
-
(2009)
Gynecol. Oncol.
-
-
Chua, T.C.1
Liauw, W.2
Robertson, G.3
Morris, D.L.4
-
2
-
-
0032077205
-
Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study
-
Eisenkop S.M., Friedman R.L., and Wang H.J. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol. Oncol. 69 (1998) 103-108
-
(1998)
Gynecol. Oncol.
, vol.69
, pp. 103-108
-
-
Eisenkop, S.M.1
Friedman, R.L.2
Wang, H.J.3
-
3
-
-
0041622805
-
Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study
-
Eisenkop S.M., Spirtos N.M., Friedman R.L., Lin W.C.M., Pisani A.L., and Perticucci S. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol. Oncol. 90 (2003) 390-396
-
(2003)
Gynecol. Oncol.
, vol.90
, pp. 390-396
-
-
Eisenkop, S.M.1
Spirtos, N.M.2
Friedman, R.L.3
Lin, W.C.M.4
Pisani, A.L.5
Perticucci, S.6
-
4
-
-
33750145025
-
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma?
-
Chi D.S., Eisenhauer E.L., Lang J., Huh J., Haddad L., Abu-Rustum N.R., et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma?. Gynecol. Oncol. 103 (2006) 559-564
-
(2006)
Gynecol. Oncol.
, vol.103
, pp. 559-564
-
-
Chi, D.S.1
Eisenhauer, E.L.2
Lang, J.3
Huh, J.4
Haddad, L.5
Abu-Rustum, N.R.6
-
5
-
-
34548491626
-
Gynecologic Oncology Group Study. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study
-
Winter III W.E., Maxwell G.L., Tian C., Carlson J.W., Ozols R.F., Rose P.G., et al. Gynecologic Oncology Group Study. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J. Clin. Oncol. 25 (2007) 3621-3627
-
(2007)
J. Clin. Oncol.
, vol.25
, pp. 3621-3627
-
-
Winter III, W.E.1
Maxwell, G.L.2
Tian, C.3
Carlson, J.W.4
Ozols, R.F.5
Rose, P.G.6
-
6
-
-
67349224121
-
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
-
Chi D.S., Eisenhauer E.L., Zivanovic O., Sonoda Y., Abu-Rustum N.R., Levine D.A., et al. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol. Oncol. 114 (2009) 26-31
-
(2009)
Gynecol. Oncol.
, vol.114
, pp. 26-31
-
-
Chi, D.S.1
Eisenhauer, E.L.2
Zivanovic, O.3
Sonoda, Y.4
Abu-Rustum, N.R.5
Levine, D.A.6
-
7
-
-
57649083923
-
Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis
-
Bristow R.E., Puri I., and Chi D.S. Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis. Gynecol. Oncol. 112 (2009) 265-274
-
(2009)
Gynecol. Oncol.
, vol.112
, pp. 265-274
-
-
Bristow, R.E.1
Puri, I.2
Chi, D.S.3
-
8
-
-
29144450706
-
Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon
-
Aletti G.D., Gostout B.S., Podratz K.C., and Cliby W.A. Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon. Gynecol. Oncol. 100 (2006) 33-37
-
(2006)
Gynecol. Oncol.
, vol.100
, pp. 33-37
-
-
Aletti, G.D.1
Gostout, B.S.2
Podratz, K.C.3
Cliby, W.A.4
|